Liquidia Technologies (NASDAQ:LQDA) CAO Dana Boyle Sells 1,238 Shares

Liquidia Technologies, Inc. (NASDAQ:LQDA) CAO Dana Boyle sold 1,238 shares of the company’s stock in a transaction on Monday, October 13th. The shares were sold at an average price of $23.41, for a total transaction of $28,981.58. Following the completion of the sale, the chief accounting officer directly owned 185,411 shares of the company’s stock, valued at $4,340,471.51. This trade represents a 0.66% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Dana Boyle also recently made the following trade(s):

• On Monday, July 28th, Dana Boyle sold 1,063 shares of Liquidia Technologies stock. The shares were sold at an average price of $19.54, for a total transaction of $20,771.02.

Liquidia Technologies Price Performance

Shares of Liquidia Technologies stock opened at $23.16 on Thursday. Liquidia Technologies, Inc. has a 52-week low of $9.71 and a 52-week high of $29.94. The stock has a market capitalization of $1.99 billion, a price-to-earnings ratio of -13.62 and a beta of 0.15. The company has a fifty day moving average of $25.05 and a 200-day moving average of $18.50. The company has a debt-to-equity ratio of 9.84, a quick ratio of 2.41 and a current ratio of 2.49.

Liquidia Technologies (NASDAQ:LQDA) last announced its quarterly earnings data on Tuesday, August 12th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.43) by ($0.06). Liquidia Technologies had a negative net margin of 732.17% and a negative return on equity of 232.96%. The business had revenue of $8.84 million during the quarter, compared to analysts’ expectations of $3.90 million. The firm’s revenue for the quarter was up 141.5% on a year-over-year basis. Equities research analysts expect that Liquidia Technologies, Inc. will post -1.51 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in LQDA. GAMMA Investing LLC raised its holdings in Liquidia Technologies by 2,342.7% in the 1st quarter. GAMMA Investing LLC now owns 43,675 shares of the company’s stock worth $644,000 after purchasing an additional 41,887 shares in the last quarter. Rhumbline Advisers raised its holdings in Liquidia Technologies by 6.0% in the 1st quarter. Rhumbline Advisers now owns 85,463 shares of the company’s stock worth $1,261,000 after purchasing an additional 4,811 shares in the last quarter. SG Americas Securities LLC bought a new position in Liquidia Technologies in the 1st quarter worth $911,000. Valmark Advisers Inc. raised its holdings in Liquidia Technologies by 7.4% in the 1st quarter. Valmark Advisers Inc. now owns 18,641 shares of the company’s stock worth $275,000 after purchasing an additional 1,283 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its holdings in Liquidia Technologies by 2.9% in the 1st quarter. Bank of New York Mellon Corp now owns 194,131 shares of the company’s stock worth $2,863,000 after purchasing an additional 5,547 shares in the last quarter. 64.54% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently commented on LQDA shares. HC Wainwright reiterated a “buy” rating and set a $35.00 price target on shares of Liquidia Technologies in a report on Monday, October 6th. Raymond James Financial upped their price target on shares of Liquidia Technologies from $33.00 to $41.00 and gave the company a “strong-buy” rating in a report on Wednesday, August 13th. Jefferies Financial Group started coverage on shares of Liquidia Technologies in a report on Friday, August 15th. They set a “buy” rating and a $43.00 price target for the company. Needham & Company LLC upped their price target on shares of Liquidia Technologies from $32.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, August 12th. Finally, Wells Fargo & Company upped their price target on shares of Liquidia Technologies from $25.00 to $31.00 and gave the company an “overweight” rating in a report on Wednesday, August 13th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $32.38.

About Liquidia Technologies

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).